Erasca, Inc.
Erasca is a clinical-stage precision oncology company developing therapies targeting RAS/MAPK pathway-driven cancers.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
August 2026
July 2026
Erasca is a clinical-stage precision oncology company developing therapies targeting RAS/MAPK pathway-driven cancers.
November 2026
October 2026
August 2026
July 2026